Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Sterling Pharma buys CiVentiChem site

by Michael McCoy
April 5, 2019 | A version of this story appeared in Volume 97, Issue 14

 

The drug services firm Sterling Pharma Solutions has acquired CiVentiChem’s US facility in Cary, North Carolina. Sterling, which calls itself the UK’s largest contract maker of active pharmaceutical ingredients, says the purchase will give it a presence in North America, where 70% of its customers are. The Cary site has development labs and kilogram-scale drug chemical suites. CiVentiChem will continue to operate out of a separate facility in India.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.